Amilal Bhat

Canadian Journal of Urology, Vol.30, No.2, pp. 11462-11462, 2023

Abstract This article has no abstract. More >

Roger S. Kirby

Canadian Journal of Urology, Vol.30, No.2, pp. 11459-11461, 2023

Abstract This article has no abstract. More >

Leonard G. Gomella

Canadian Journal of Urology, Vol.30, No.2, pp. 11457-11458, 2023

Abstract This article has no abstract. More >

Andrew M. Higgins¹, Michael J. Wolf², Russell E. N. Becker¹, Khurshid R. Ghani¹

Canadian Journal of Urology, Vol.30, No.3, pp. 11574-11582, 2023

Abstract In North America, ureteroscopy has become the most popular treatment modality for upper urinary tract urinary calculi. Herein we describe our technique for the treatment of renal stones with flexible ureteroscopy and high-power holmium laser lithotripsy. We discuss preoperative planning, intraoperative strategies, and laser settings for a high-frequency dusting technique with the goal to provide optimal patient outcomes. More >

Dean S. Elterman¹, Bruce Gao¹, Kevin C. Zorn², Naeem Bhojani², Alexis Te³, Bilal Chughtai³, Steven A. Kaplan

Canadian Journal of Urology, Vol.30, No.3, pp. 11568-11573, 2023

Abstract Benign prostatic hyperplasia (BPH) is a common and progressive disease affecting aging men which has a significant impact on quality of life. The Optilume BPH Catheter System (Optilume BPH) is a prostatic dilation system that combines balloon dilation with a localized transfer of paclitaxel to maintain long term patency. Optilume BPH can be deployed using standard rigid cystoscopy without general anesthesia in an office setting. Prospective data indicate that Optilume BPH has favorable functional and sexual patient outcomes. Readers will familiarize themselves with Optilume BPH, significant historical studies and the technique for deploying Optilume BPH. More >

Tariq Abdul Hamid¹, Amr Elmekresh¹, Almas Zulfiquar Parkar², Mohamad Motaz Al Masri¹, Yaser Saeedi¹

Canadian Journal of Urology, Vol.30, No.3, pp. 11562-11567, 2023

Abstract Monkeypox virus (MPV) is a rare zoonotic infection caused by an orthopoxvirus. The sudden outbreak of more than 3000 MPV infection from 50 countries has led the WHO to declare the infection as an “evolving threat of moderate public health concern”. Here, we describe a case series of two cases of the MPV with a similar onset of cutaneous lesions in the genital area but with different progression in 35 and 41-year-old males respectively. Both of our patients were reported heterosexual with a 10-day prior history of unprotected sexual activity with a sex worker. Case… More >

Erin Howells¹, Lucas Wigston², Gavin Mackie¹, Ben Tran³, Louise Nott⁴

Canadian Journal of Urology, Vol.30, No.3, pp. 11558-11561, 2023

Abstract Fumarate hydratase deficient (FHdef) renal cell carcinoma (RCC) is rare, highly aggressive and is believed to arise mostly in the setting of hereditary leiomyomatosis RCC (HLRCC) syndrome with a germline mutation of fumarate hydratase (FH) gene. There is currently little evidence regarding the most effective systemic treatment for advanced FHdef RCC. We present three cases of metastatic FHdef RCC, all achieving tumor response with combination immunotherapy ipilimumab and nivolumab (Ipi/Nivo). A 50-year-old male, a 27-year-old male and a 48-year-old female. The clinical features, diagnosis and medical imaging are reviewed. More >

Alon Lazarovich¹, Thenappan Chandrasekar², Alina Basnet³, Gennady Bratslavsky⁴, Hanan Goldberg⁴

Canadian Journal of Urology, Vol.30, No.3, pp. 11551-11557, 2023

Abstract Introduction: Prostate-specific antigen (PSA) testing remains a controversial issue. However, most urological guidelines recommend PSA testing in men aged 55-69 through a shared decision-making process with the patient. The impact of prior cancer diagnosis on PSA testing is not well-known. To compare PSA testing in men aged 55-69 years with and without a history of cancer (excluding prostate cancer patients).
Materials and methods: Utilizing the National Health Interview Survey (NHIS), a retrospective cross-sectional study during the year 2018 was carried out. Multivariable logistic regression analysis was implemented to demonstrate potential associations with PSA testing and assess the… More >

David-Dan Nguyen^1,*, Massine Fellouah^2,*, Anna-Lisa V. Nguyen³, David-Christian Kazu⁴, Isabel Baltzan⁵, Muhieddine Labban⁶, Shubha De⁷, Kevin C. Zorn⁸, Bilal Chughtai⁹, Dean S. Elterman¹, Quoc-Dien Trinh⁶, Naeem Bhojani⁸

Canadian Journal of Urology, Vol.30, No.3, pp. 11546-11550, 2023

Abstract Introduction: 5α-reductase inhibitors (5ARI) are commonly prescribed medications. There is ongoing controversy about the adverse events of these medications. The aim of this study is to characterize lawsuits in Canada involving medical complications of 5ARIs use.
Materials and methods: Legal cases were queried from CanLII. Cases were included if they involved a party taking a 5ARI who alleged an adverse event. Relevant full cases were retained, and pertinent characteristics were extracted with the help of a legal expert.
Results: Our deduplicated search yielded 67 unique legal documents from December 2013 to February 2019. Twelve of these documents met… More >

Jonathan E. Heinlen

Canadian Journal of Urology, Vol.30, No.3, pp. 11545-11545, 2023

Abstract This article has no abstract. More >